Is Reviva Pharmaceuticals Holdings, Inc. (RVPH) a Smart Choice in Biotechnology Thursday?

A rating of 79 puts Reviva Pharmaceuticals Holdings, Inc. (RVPH) near the top of the Biotechnology industry according to InvestorsObserver. Reviva Pharmaceuticals Holdings, Inc.'s score of 79 means it scores higher than 79% of stocks in the industry. Reviva Pharmaceuticals Holdings, Inc. also received an overall rating of 62, putting it above 62% of all stocks. Biotechnology is ranked 43 out of the 148 industries.

RVPH has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on RVPH!

See Full RVPH Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Reviva Pharmaceuticals Holdings, Inc. Stock Today?

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock is down -8% while the S&P 500 has risen 0.07% as of 10:26 AM on Thursday, Nov 16. RVPH has fallen -$0.40 from the previous closing price of $5.00 on volume of 629,998 shares. Over the past year the S&P 500 is higher by 13.83% while RVPH has risen 6.24%. RVPH lost -$1.36 per share the over the last 12 months. Click Here to get the full Stock Report for Reviva Pharmaceuticals Holdings, Inc. stock.